Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Cash Flow Quality Index
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Cash Flow Quality Index of 0.58x as of September 2025. Operating cash flow of CN¥133.43 Million is below net income of CN¥230.43 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Zhejiang CONBA Pharmaceutical Co Ltd (600572) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Quality Index (2003–2025)
Historical Cash Flow Quality Index for Zhejiang CONBA Pharmaceutical Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600572 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year earnings quality comparison for Zhejiang CONBA Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Zhejiang CONBA Pharmaceutical Co Ltd (600572) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.99x | CN¥942.61 Million | CN¥474.36 Million | ▲ +22.2% |
| 2024 | 1.63x | CN¥1.01 Billion | CN¥622.42 Million | ▲ +22.1% |
| 2023 | 1.33x | CN¥898.64 Million | CN¥674.72 Million | ▼ -47.0% |
| 2022 | 2.51x | CN¥1.16 Billion | CN¥460.09 Million | ▲ +498.2% |
| 2021 | 0.42x | CN¥889.94 Million | CN¥2.12 Billion | ▼ -81.5% |
| 2020 | 2.28x | CN¥1.25 Billion | CN¥549.20 Million | ▲ +237.0% |
| 2018 | 0.68x | CN¥545.78 Million | CN¥808.34 Million | ▼ -30.8% |
| 2017 | 0.98x | CN¥712.27 Million | CN¥729.97 Million | ▼ -59.3% |
| 2016 | 2.40x | CN¥969.71 Million | CN¥404.14 Million | ▲ +45.4% |
| 2015 | 1.65x | CN¥831.26 Million | CN¥503.71 Million | ▲ +94.5% |
| 2014 | 0.85x | CN¥617.43 Million | CN¥727.75 Million | ▲ +63.7% |
| 2013 | 0.52x | CN¥235.36 Million | CN¥454.22 Million | ▼ -27.7% |
| 2012 | 0.72x | CN¥245.76 Million | CN¥342.80 Million | ▲ +16.6% |
| 2011 | 0.61x | CN¥188.36 Million | CN¥306.43 Million | ▼ -2.0% |
| 2010 | 0.63x | CN¥125.93 Million | CN¥200.83 Million | ▼ -57.0% |
| 2009 | 1.46x | CN¥153.39 Million | CN¥105.20 Million | ▲ +37.0% |
| 2008 | 1.06x | CN¥98.56 Million | CN¥92.60 Million | ▲ +50.1% |
| 2007 | 0.71x | CN¥79.98 Million | CN¥112.83 Million | ▼ -38.8% |
| 2006 | 1.16x | CN¥71.20 Million | CN¥61.49 Million | ▼ -53.6% |
| 2005 | 2.49x | CN¥117.65 Million | CN¥47.17 Million | ▲ +18.3% |
| 2004 | 2.11x | CN¥65.47 Million | CN¥31.05 Million | ▲ +26.8% |
| 2003 | 1.66x | CN¥66.64 Million | CN¥40.07 Million | — |